| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-34720-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-44131 | |||
| BSA Free | NBP2-61142-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-44132 | |||
| BSA Free | NBP2-61147-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-44070 | |||
| BSA Free | NBP2-61642-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61147 | |||
| BSA Free | NBP2-61147-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-48129 | |||
| Azide and BSA Free | NBP3-11452 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-61600-100ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-79926 | |||
![Immunohistochemistry-Paraffin: TYRP1 Antibody [NBP1-88370] - Analysis in human skin and cerebral cortex tissues. Corresponding TYRP1 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/TYRP1-Antibody-Immunohistochemistry-Paraffin-NBP1-88370-img0012.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: TYRP1 Antibody [NBP1-88370] - Analysis in human skin and cerebral cortex tissues. Corresponding TYRP1 RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Western Blot: TYRP1 Antibody [NBP1-88370] - Analysis in control (vector only transfected HEK293T lysate) and TYRP1 over-expression lysate (Co-expressed with a C-terminal myc-DDK tag (3.1 kDa) in mammalian HEK293T cells).](http://images.novusbio.com/fullsize/TYRP1-Antibody-Western-Blot-NBP1-88370-img0011.jpg)
![Immunocytochemistry/Immunofluorescence: TYRP1 Antibody [NBP1-88370] - Staining of human cell line SK-MEL-30 shows localization to vesicles. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/TYRP1-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-88370-img0005.jpg)
![Immunohistochemistry-Paraffin: TYRP1 Antibody [NBP1-88370] - Staining of human cerebral cortex shows no positivity in neurons as expected.](http://images.novusbio.com/fullsize/TYRP1-Antibody-Immunohistochemistry-Paraffin-NBP1-88370-img0016.jpg)
![Western Blot: TYRP1 Antibody [NBP1-88370] - Analysis in human cell line SK-MEL-30.](http://images.novusbio.com/fullsize/TYRP1-Antibody-Western-Blot-NBP1-88370-img0007.jpg)
![Immunohistochemistry-Paraffin: TYRP1 Antibody [NBP1-88370] - Staining of human endometrium shows no positivity in glandular cells as expected.](http://images.novusbio.com/fullsize/TYRP1-Antibody-Immunohistochemistry-Paraffin-NBP1-88370-img0013.jpg)
![Immunohistochemistry-Paraffin: TYRP1 Antibody [NBP1-88370] - Staining of human rectum shows moderate to strong cytoplasmic positivity in a subset of glandular cells and cells in stroma.](http://images.novusbio.com/fullsize/TYRP1-Antibody-Immunohistochemistry-Paraffin-NBP1-88370-img0014.jpg)
![Immunohistochemistry-Paraffin: TYRP1 Antibody [NBP1-88370] - Staining of human skin shows moderate to strong cytoplasmic positivity in melanocytes.](http://images.novusbio.com/fullsize/TYRP1-Antibody-Immunohistochemistry-Paraffin-NBP1-88370-img0015.jpg)
![Western Blot: TYRP1 Antibody [NBP1-69542] - Sample Tissue: Human 786-0 Antibody Dilution: 1.0 ug/ml](http://images.novusbio.com/fullsize/TYRP1-Antibody-Western-Blot-NBP1-69542-img0004.jpg "Western Blot: TYRP1 Antibody [NBP1-69542] - Sample Tissue: Human 786-0 Antibody Dilution: 1.0 ug/ml")
![Immunohistochemistry-Paraffin: TYRP1 Antibody [NBP1-69542] - Human Skin.](http://images.novusbio.com/fullsize/TYRP1-Antibody-Immunohistochemistry-Paraffin-NBP1-69542-img0003.jpg)
![Western Blot: TYRP1 Antibody [NBP1-69542] - This Anti-TYRP1 antibody was used in Western Blot of 721_B tissue lysate at a concentration of 1ug/ml.](http://images.novusbio.com/fullsize/TYRP1-Antibody-Western-Blot-NBP1-69542-img0001.jpg)
![Western Blot: TYRP1 Antibody [NBP1-69542] - Sample Tissue: Human 721_B, Lane A: Primary Antibody, Lane B: Primary Antibody + Blocking Peptide, Primary Antibody Concentration: 1ug/ml, Peptide Concentration: 5.0 ug/ml, Lysate Quantity: 25ug/lane/lane, Gel Concentration: 12%](http://images.novusbio.com/fullsize/TYRP1-Antibody-Western-Blot-NBP1-69542-img0002.jpg)
![Western Blot: TYRP1 Antibody (CL4906) [NBP2-61142] - Western blot analysis in human cell line SK-MEL-30.](http://images.novusbio.com/fullsize/TYRP1-Antibody-CL4906-Western-Blot-NBP2-61142-img0003.jpg "Western Blot: TYRP1 Antibody (CL4906) [NBP2-61142] - Western blot analysis in human cell line SK-MEL-30.")
![Immunocytochemistry/Immunofluorescence: TYRP1 Antibody (CL4906) [NBP2-61142] - Staining of SK-MEL-30 cells using the Anti-TYRP1 monoclonal antibody, showing specific staining in the vesicles in green. Microtubule- and nuclear probes are visualized in red and blue, respectively (where available).](http://images.novusbio.com/fullsize/TYRP1-Antibody-CL4906-Immunocytochemistry-Immunofluorescence-NBP2-61142-img0004.jpg)
![Immunohistochemistry: TYRP1 Antibody (CL4906) [NBP2-61142] - Staining of human tonsil shows no positivity in lymphoid cells as expected (negative control).](http://images.novusbio.com/fullsize/TYRP1-Antibody-CL4906-Immunohistochemistry-NBP2-61142-img0002.jpg)
![Immunohistochemistry: TYRP1 Antibody (CL4906) [NBP2-61142] - Staining of human skin shows strong cytoplasmic immunoreactivity in melanocytes.](http://images.novusbio.com/fullsize/TYRP1-Antibody-CL4906-Immunohistochemistry-NBP2-61142-img0001.jpg)
![Western Blot: TYRP1 Antibody (CL4917) [NBP2-61147] - Western blot analysis in human cell line SK-MEL-30.](http://images.novusbio.com/fullsize/TYRP1-Antibody-CL4917-Western-Blot-NBP2-61147-img0003.jpg "Western Blot: TYRP1 Antibody (CL4917) [NBP2-61147] - Western blot analysis in human cell line SK-MEL-30.")
![Immunocytochemistry/Immunofluorescence: TYRP1 Antibody (CL4917) [NBP2-61147] - Staining of SK-MEL-30 cells using the Anti-TYRP1 monoclonal antibody, showing specific staining in the vesicles in green. Microtubule- and nuclear probes are visualized in red and blue, respectively (where available).](http://images.novusbio.com/fullsize/TYRP1-Antibody-CL4917-Immunocytochemistry-Immunofluorescence-NBP2-61147-img0004.jpg)
![Immunohistochemistry: TYRP1 Antibody (CL4917) [NBP2-61147] - Immunohistochemical staining of human skeletal muscle shows no positivity in muscle fibers as expected (negative control).](http://images.novusbio.com/fullsize/TYRP1-Antibody-CL4917-Immunohistochemistry-NBP2-61147-img0002.jpg)
![Immunohistochemistry: TYRP1 Antibody (CL4917) [NBP2-61147] - Immunohistochemical staining of human skin shows strong cytoplasmic immunoreactivity in melanocytes.](http://images.novusbio.com/fullsize/TYRP1-Antibody-CL4917-Immunohistochemistry-NBP2-61147-img0001.jpg)
![Western Blot: TYRP1 Antibody (CL4923) [NBP2-61642] - Analysis in human cell line SK-MEL-30.](http://images.novusbio.com/fullsize/TYRP1-Antibody-CL4923-Western-Blot-NBP2-61642-img0003.jpg "Western Blot: TYRP1 Antibody (CL4923) [NBP2-61642] - Analysis in human cell line SK-MEL-30.")
![Immunocytochemistry/Immunofluorescence: TYRP1 Antibody (CL4923) [NBP2-61642] - Staining of SK-MEL-30 cells using the Anti-TYRP1 monoclonal antibody, showing specific staining in the vesicles in green. Microtubule- and nuclear probes are visualized in red and blue, respectively (where available).](http://images.novusbio.com/fullsize/TYRP1-Antibody-CL4923-Immunocytochemistry-Immunofluorescence-NBP2-61642-img0004.jpg)
![Immunohistochemistry-Paraffin: TYRP1 Antibody (CL4923) [NBP2-61642] - Staining of human tonsil shows no positivity in lymphoid cells as expected (negative control).](http://images.novusbio.com/fullsize/TYRP1-Antibody-CL4923-Immunohistochemistry-NBP2-61642-img0002.jpg)
![Immunohistochemistry-Paraffin: TYRP1 Antibody (CL4923) [NBP2-61642] - Staining of human skin shows strong cytoplasmic immunoreactivity in melanocytes.](http://images.novusbio.com/fullsize/TYRP1-Antibody-CL4923-Immunohistochemistry-NBP2-61642-img0001.jpg)
![Immunohistochemistry-Paraffin: TYRP1 Antibody (SPM611) [NBP2-44620] - Human Melanoma stained with TYRP1 Monoclonal Antibody (SPM611)](http://images.novusbio.com/fullsize/TYRP1-Antibody-SPM611-Immunohistochemistry-Paraffin-NBP2-44620-img0001.jpg "Immunohistochemistry-Paraffin: TYRP1 Antibody (SPM611) [NBP2-44620] - Human Melanoma stained with TYRP1 Monoclonal Antibody (SPM611)")
![Immunohistochemistry-Paraffin: TYRP1 Antibody (TYRP1/1986) [NBP2-61599] - Formalin-fixed, paraffin-embedded human Skin stained withTYRP1 Mouse Monoclonal Antibody (TYRP1/1986)](http://images.novusbio.com/fullsize/TYRP1-Antibody-TYRP1-1986-Immunohistochemistry-Paraffin-NBP2-61599-img0001.jpg "Immunohistochemistry-Paraffin: TYRP1 Antibody (TYRP1/1986) [NBP2-61599] - Formalin-fixed, paraffin-embedded human Skin stained withTYRP1 Mouse Monoclonal Antibody (TYRP1/1986)")
![Protein Array: TYRP1 Antibody (TYRP1/1986) [NBP2-61599] - Analysis of Protein Array containing more than 19,000 full-length human proteins using TYRP1 Antibody (TYRP1/1986). Z- and S- Score: The Z-score represents the strength of a signal that a monoclonal antibody (Monoclonal Antibody) (in combination with a fluorescently-tagged anti-IgG secondary antibody) produces when binding to a particular protein on the HuProt(TM) array. Z-scores are described in units of standard deviations (SD?s) above the mean value of all signals generated on that array. If targets on HuProt(TM) are arranged in descending order of the Z-score, the S-score is the difference (also in units of SD?s) between the Z-score. S-score therefore represents the relative target specificity of a Monoclonal Antibody to its intended target. A Monoclonal Antibody is considered to specific to its intended target, if the Monoclonal Antibody has an S-score of at least 2.5.](http://images.novusbio.com/fullsize/TYRP1-Antibody-TYRP1-1986-Protein-Array-NBP2-61599-img0003.jpg)
![Immunohistochemistry-Paraffin: TYRP1 Antibody (TYRP1/3280) [NBP2-79792] - Formalin-fixed, paraffin-embedded human Skin stained with TYRP1 Antibody (TYRP1/3280).](http://images.novusbio.com/fullsize/TYRP1-Antibody-TYRP1-3280-Immunohistochemistry-Paraffin-NBP2-79792-img0001.jpg "Immunohistochemistry-Paraffin: TYRP1 Antibody (TYRP1/3280) [NBP2-79792] - Formalin-fixed, paraffin-embedded human Skin stained with TYRP1 Antibody (TYRP1/3280).")
![Protein Array: TYRP1 Antibody (TYRP1/3280) [NBP2-79792] - Analysis of Protein Array containing more than 19,000 full-length human proteins using TYRP1 Antibody (TYRP1/3280) Z- and S- Score: The Z-score represents the strength of a signal that a monoclonal antibody (Monoclonal Antibody) (in combination with a fluorescently-tagged anti-IgG secondary antibody) produces when binding to a particular protein on the HuProt(TM) array. Z-scores are described in units of standard deviations (SD's) above the mean value of all signals generated on that array. If targets on HuProt(TM) are arranged in descending order of the Z-score, the S-score is the difference (also in units of SD's) between the Z-score. S-score therefore represents the relative target specificity of a Monoclonal Antibody to its intended target. A Monoclonal Antibody is considered to specific to its intended target, if the Monoclonal Antibody has an S-score of at least 2.5](http://images.novusbio.com/fullsize/TYRP1-Antibody-TYRP1-3280-Protein-Array-NBP2-79792-img0002.jpg)
![Flow Cytometry: TYRP1 Antibody (TA99) - Chimeric - BSA Free [NBP3-43531] - Mouse splenocytes (A), B16F10 murine melanoma cells (B), KPC3 pacreas carcinoma cells (C) and KPC3 cells transfected with the TYRP1 gene (D) were fixed using 2% PFA, permeabilised using 0.5% Triton and were subject to a primary treatment of either buffer, mouse-IgG1 chimeric 2C11 or NBP3-43531 (TA99) (indicated above plots) before a secondary treatment with buffer, goat anti-mouse Ig-allophycocyanin (G-aM Ig-APC) or anti-HisTag-APC (aHis-APC) antibodies (indicated beside plots). In panel A, splenocytes were also stained with a commercially available anti-CD3 (2C11) antibody conjugated to phycoerythrin (PE); all cells (i-v) were CD3 and thus PE positive. In subpanel 'A v' an increase in APC fluorescence intensity (FI(APC)) indicates binding of aHis-APC to 2C11 bound to CD3 at the cell surface. Some Ig containing proteins expressed by the splenocytes may explain the increase in APC fluorescence in subpanel 'A iii'. In panel B an increase in FI(APC) in subpanel 'iii' indicates that TA99 binds to heavily expressed TYRP1 at B16F10 cell surfaces and is then detectable using an G-aM Ig-APC antibody. Conversely, G-aM Ig-APC did not detect 2C11 at the cell surface, whereas a subset of cells with 2C11 bound to the surface were detectable using aHis-APC. Panel C shows that TYRP1 is not detectable in KPC3 carcinoma cells ('Ci, iii, v') as expected, and that again, aHis-APC is able to detect a small subset of CD3 expressing cells ('C vi'). When transfected with the TYRP1 gene, KPC3 cells then strongly express TYRP1 and it becomes detectable ('D iii'). A small subset of CD3 positive cells was again detectable in TYRP1 transfected KPC3 cells ('D vi'). All analyses were made using FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/nbp3-43531_rabbit-tyrp1-mab-ta99-chimeric-azide-and-bsa-free-7420252226520.png "Flow Cytometry: TYRP1 Antibody (TA99) - Chimeric - BSA Free [NBP3-43531] - Mouse splenocytes (A), B16F10 murine melanoma cells (B), KPC3 pacreas carcinoma cells (C) and KPC3 cells transfected with the TYRP1 gene (D) were fixed using 2% PFA, permeabilised using 0.5% Triton and were subject to a primary treatment of either buffer, mouse-IgG1 chimeric 2C11 or NBP3-43531 (TA99) (indicated above plots) before a secondary treatment with buffer, goat anti-mouse Ig-allophycocyanin (G-aM Ig-APC) or anti-HisTag-APC (aHis-APC) antibodies (indicated beside plots). In panel A, splenocytes were also stained with a commercially available anti-CD3 (2C11) antibody conjugated to phycoerythrin (PE); all cells (i-v) were CD3 and thus PE positive. In subpanel 'A v' an increase in APC fluorescence intensity (FI(APC)) indicates binding of aHis-APC to 2C11 bound to CD3 at the cell surface. Some Ig containing proteins expressed by the splenocytes may explain the increase in APC fluorescence in subpanel 'A iii'. In panel B an increase in FI(APC) in subpanel 'iii' indicates that TA99 binds to heavily expressed TYRP1 at B16F10 cell surfaces and is then detectable using an G-aM Ig-APC antibody. Conversely, G-aM Ig-APC did not detect 2C11 at the cell surface, whereas a subset of cells with 2C11 bound to the surface were detectable using aHis-APC. Panel C shows that TYRP1 is not detectable in KPC3 carcinoma cells ('Ci, iii, v') as expected, and that again, aHis-APC is able to detect a small subset of CD3 expressing cells ('C vi'). When transfected with the TYRP1 gene, KPC3 cells then strongly express TYRP1 and it becomes detectable ('D iii'). A small subset of CD3 positive cells was again detectable in TYRP1 transfected KPC3 cells ('D vi'). All analyses were made using FACSCanto flow-cytometer.")